Clinically available intracorporeal left ventricular assist devices

Progress in Cardiovascular Diseases

Volumn 43, Issue 1, 2000, Pages 37-46

  Mccarthy, Patrick M ^a,b   Hoercher, Katherine ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Dept Thorac Cardiovasc S ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSISTED CIRCULATION; BLEEDING; DEVICE; FOOD AND DRUG ADMINISTRATION; HEART RIGHT VENTRICLE FAILURE; HUMAN; INFECTION; REVIEW; SAFETY; SURVIVAL RATE; THROMBOEMBOLISM;

EID: 0033929204     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2000.7200     Document Type: Article

References (30)

1. Frazier OH, Rose EA, McCarthy PM, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg. 222:1995;327-336
2. McCarthy PM, Portner PM, Oyer PE, et al. Clinical experience with the Novacor ventricular assist system: Bridge-to-transplant and the transition to chronic application. J Thorac Cardiovasc Surg. 102:1991;578-587
3. Oz MC, Argenziano M, Catanese KA, et al. Bridge experience with long-term implantable left ventricular assist devices: Are they an alternative to transplantation? Circulation. 95:1997;1844-1852
4. McCarthy PM, Sabik JF. Implantable circulatory support devices as a bridge to heart transplantation. Semin Thorac Cardiovasc Surg. 6:1994;174-180
5. Savage RM, McCarthy PM, Stewart WJ, et al. Intraoperative transesophageal echocardiographic evaluation of the implantable left ventricular assist device. Vid J Echocardiography. 2:1992;125-136
6. McCarthy PM. Implantable left ventricular assist device insertion techniques. Op Tech Thorac Cardiovasc Surg. 4:1999;277-300
7. Parnis SM, McGee MG, Igo SR, et al. Anatomic considerations for abdominally placed permanent left ventricular assist devices. ASAIO Trans. 35:1989;728-730
8. Pennington DG, McBride LR, Swartz MT. Implantation technique for the Novacor left ventricular assist system. J Thorac Cardiovasc Surg. 108:1994;604-608
9. Insler S, Savage RM, Wallace L, et al. The use of the implantable ventricular assist device in the treatment of right ventricular failure. J Cardiothorac Vasc Anesth. 10:1996;672-677
10. McCarthy PM, Smedira NG. Implantable LVAD insertion in patients with previous heart surgery. J Heart Lung Transplant. 2000;. (in press)
11. Wang IW, Kottke-Marchant K, Vargo RL, et al. Hemostatic profiles of HeartMate ventricular assist device recipients. ASAIO J. 41:1995;M782-M787
12. Kaplon RJ, Gillinov AM, Smedira NG, et al. Vitamin K reduces bleeding in left ventricular assist device recipients. J Heart Lung Transplant. 18:1999;346-350
13. Goldstein DJ, Seidomridge JA, Chen JM, et al. Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg. 59:1995;1063-1067
14. Oz MC, Rose EA, Slater JP, et al. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term ventricular assist devices. J Am Coll Cardiol. 24:1994;1688-1691
15. McCarthy PM, Smedira NO, Vargo RL, et al. One hundred patients with the Heartmate left ventricular assist device: Evolving concepts and technology. J Thorac Cardiovasc Surg. 115:1998;904-912
16. McCarthy PM, Savage RM, Fraser CD, et al. Hemodynamic and physiologic changes during support with an implantable left ventricular assist device. J Thorac Cardiovasc Surg. 109:1995;409-418
17. James KB, McCarthy PM, Thomas JD, et al. The effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation. 92:1995;191-195
18. Helman DN, Morales DL, Edwards NM, et al. Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy. Ann Thorac Surg. 68:1999;1187-1194
19. Catanese KA, Goldstein DJ, Williams DL, et al. Outpatient left ventricular assist device support: A destination rather than a bridge. Ann Thorac Surg. 62:1996;646-652
20. McCarthy PM, Schmitt SK, Vargo RL, et al. LVAD infections: Implications for permanent use of the device. Ann Thorac Surg. 61:1996;359-365
21. Argenziano M, Catanese KA, Moazaml N, et al. The influence of infection on survival and successful transplantation in patents with left ventricular assist devices. J Heart Lung Transplant. 16:1997;822-831
22. Copeland JG III, Hetzer R, Holman WL, et al. Discussion of infection. Ann Thorac Surg. 61:1996;372-373
23. FDA Summary of Safety and Effectiveness. 1998
24. Mehta SM, Pae WE. Erosion of inlet cannula of left ventricular assist device manifested as innocuous bleeding in stable patient: Lessons learned in prevention of catastrophic consequences. J Thorac Cardiovasc Surg. 112:1996;544-545
25. Scheld HH, Soeparwata R, Schmid C, et al. Rupture of inflow conduits in the TCI-HeartMate system. J Thorac Cardiovasc Surg. 114:1997;287-289
26. Graham TR, Dasse K, Coumbe A, et al. Neo-intimal development on textured biomaterial surfaces during clinical use of an implantable left ventricular assist device. Eur J Cardiothorac Surg. 4:1990;182-190
27. Rose EA, Levin HR, Oz M, et al. Artificial circulatory support with textured interior surfaces: A counterintuitive approach to minimizing thromboembolism. Circulation. 90:1994;1187-1191
28. Ankersmit HJ, Itescu S. Immunobiology of left ventricular assist device (LVAD) implantation. J Card Surg. 2000;. (in press)
29. Ankersmit HJ, Tugulea S, Spanier T, et al. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet. 354:1999;550-555
30. Rose EA, Moskowitz AJ, Packer M, et al. The REMATCH trial: Rationale, design, and end points: Randomized evaluation of mechanical assistance for the treatment of congestive heart failure. Ann Thorac Surg. 67:1999;723-730